Composite  ||| S:0 E:10 ||| JJ
tissue  ||| S:10 E:17 ||| NN
allotransplantation  ||| S:17 E:37 ||| VBZ
Recently ||| S:37 E:45 ||| RB
,  ||| S:45 E:47 ||| ,
composite  ||| S:47 E:57 ||| JJ
tissue  ||| S:57 E:64 ||| NN
allotransplantation  ||| S:64 E:84 ||| NNS
was  ||| S:84 E:88 ||| VBD
introduced  ||| S:88 E:99 ||| VBN
as  ||| S:99 E:102 ||| IN
a  ||| S:102 E:104 ||| DT
potential  ||| S:104 E:114 ||| JJ
clinical  ||| S:114 E:123 ||| JJ
treatment  ||| S:123 E:133 ||| NN
for  ||| S:133 E:137 ||| IN
complex  ||| S:137 E:145 ||| JJ
reconstructive  ||| S:145 E:160 ||| JJ
procedures ||| S:160 E:170 ||| NNS
,  ||| S:170 E:172 ||| ,
including  ||| S:172 E:182 ||| VBG
tumor  ||| S:182 E:188 ||| NN
ablative  ||| S:188 E:197 ||| NN
operations ||| S:197 E:207 ||| NNS
,  ||| S:207 E:209 ||| ,
traumatic  ||| S:209 E:219 ||| JJ
injuries ||| S:219 E:227 ||| NNS
,  ||| S:227 E:229 ||| ,
and  ||| S:229 E:233 ||| CC
extensive  ||| S:233 E:243 ||| JJ
tissue  ||| S:243 E:250 ||| NN
loss  ||| S:250 E:255 ||| NN
secondary  ||| S:255 E:265 ||| JJ
to  ||| S:265 E:268 ||| TO
burns ||| S:268 E:273 ||| NNS
.  ||| S:273 E:275 ||| .
Composite  ||| S:275 E:285 ||| JJ
tissue  ||| S:285 E:292 ||| NN
allotransplantations  ||| S:292 E:313 ||| NNS
consist  ||| S:313 E:321 ||| VBP
of  ||| S:321 E:324 ||| IN
heterogeneous  ||| S:324 E:338 ||| JJ
tissues  ||| S:338 E:346 ||| NNS
including  ||| S:346 E:356 ||| VBG
skin ||| S:356 E:360 ||| NN
,  ||| S:360 E:362 ||| ,
fat ||| S:362 E:365 ||| JJ
,  ||| S:365 E:367 ||| ,
muscle ||| S:367 E:373 ||| NN
,  ||| S:373 E:375 ||| ,
nerves ||| S:375 E:381 ||| NNS
,  ||| S:381 E:383 ||| ,
lymph  ||| S:383 E:389 ||| JJ
nodes ||| S:389 E:394 ||| NN
,  ||| S:394 E:396 ||| ,
bone ||| S:396 E:400 ||| NN
,  ||| S:400 E:402 ||| ,
cartilage ||| S:402 E:411 ||| NN
,  ||| S:411 E:413 ||| ,
ligaments ||| S:413 E:422 ||| NN
,  ||| S:422 E:424 ||| ,
and  ||| S:424 E:428 ||| CC
bone  ||| S:428 E:433 ||| NN
marrow ||| S:433 E:439 ||| NN
,  ||| S:439 E:441 ||| ,
all  ||| S:441 E:445 ||| DT
presenting  ||| S:445 E:456 ||| NN
with  ||| S:456 E:461 ||| IN
different  ||| S:461 E:471 ||| JJ
antigenicity ||| S:471 E:483 ||| NN
.  ||| S:483 E:485 ||| .
Thus ||| S:485 E:489 ||| RB
,  ||| S:489 E:491 ||| ,
composite  ||| S:491 E:501 ||| JJ
tissue  ||| S:501 E:508 ||| NN
allotransplantations  ||| S:508 E:529 ||| NNS
are  ||| S:529 E:533 ||| VBP
considered  ||| S:533 E:544 ||| VBN
to  ||| S:544 E:547 ||| TO
elicit  ||| S:547 E:554 ||| VB
a  ||| S:554 E:556 ||| DT
stronger  ||| S:556 E:565 ||| JJR
response  ||| S:565 E:574 ||| NN
compared  ||| S:574 E:583 ||| VBN
with  ||| S:583 E:588 ||| IN
solid  ||| S:588 E:594 ||| JJ
organ  ||| S:594 E:600 ||| NN
transplants ||| S:600 E:611 ||| NNS
.  ||| S:611 E:613 ||| .
This  ||| S:613 E:618 ||| DT
article  ||| S:618 E:626 ||| NN
outlines  ||| S:626 E:635 ||| VBZ
different  ||| S:635 E:645 ||| JJ
experimental  ||| S:645 E:658 ||| JJ
models  ||| S:658 E:665 ||| NNS
and  ||| S:665 E:669 ||| CC
current  ||| S:669 E:677 ||| JJ
clinical  ||| S:677 E:686 ||| JJ
applications  ||| S:686 E:699 ||| NNS
of  ||| S:699 E:702 ||| IN
composite  ||| S:702 E:712 ||| JJ
tissue  ||| S:712 E:719 ||| NN
allotransplantation ||| S:719 E:738 ||| NN
.  ||| S:738 E:740 ||| .
